The role of sigmoidoscopy in colorectal cancer screening – public preferences and predicted uptake

BACKGROUND: Participation in cancer screening is crucial to maximise its benefit. In colorectal cancer (CRC) screening, stool tests or colonoscopies are commonly offered worldwide screening tests. In the German CRC screening programme, the insured can primarily choose between stool test and colonoscopy. However, sigmoidoscopy is also an evidence-based procedure to reduce CRC mortality and even prevent CRC. Based on individual preferences, we aim to estimate the uptake for either colonoscopy, sigmoidoscopy, or stool test in CRC screening. METHODS: In 2020, statutory insured individuals aged 50, 55, and 60 in Germany, Lower Saxony, were invited to participate in a discrete choice experiment (DCE). Each participant received 8 choice tasks, each of which presented two unlabelled (procedure A and B) screening alternatives defined by 6 attributes (CRC incidence and mortality, complications, preprocedural bowel preparation, need for transportation home, colonoscopy following a positive test result). Each attribute had 3 levels. To calculate the indirect utility and probability of uptake of stool testing, sigmoidoscopy, colonoscopy, and 'no screening', the preference weights of the attribute levels used to define the 4 alternatives were summed. Estimates were compared between standard screening (stool test or colonoscopy) and extended screening (+ sigmoidoscopy). External validity of the DCE was checked by comparing predicted and intended (2 items in the questionnaire) participation. RESULTS: From n = 666 valid respondents, a greater proportion of women (22.5%; 95%CI 16.2-28.9%) than men (13.4%; 95%CI 9.6-17.2%) preferred sigmoidoscopy in an extended screening scenario. Compared with standard screening, the predicted uptake for colonoscopy and the stool test as well as for 'no screening' was slightly lower when sigmoidoscopy was offered as an additional option. The extended screening could yield a slightly higher non-significant total participation in CRC screening in both women (+ 5.8%; 95%CI -0.4-12.0%) and men (+ 3.1; 95%CI -3.4-9.6%) than standard screening. Intended and preferred uptake did not differ substantially. CONCLUSIONS: A relevant proportion of the eligible population, more women than men, appears to prefer sigmoidoscopy for CRC screening when given the option. This additional option tends to increase overall predicted participation in CRC screening. Future studies are needed to evaluate the acceptance and feasibility of the additionally offered sigmoidoscopy in today's CRC screening. TRIAL REGISTRATION: DRKS00019010, 2019-11-18.

Authors

Institutions

Publication Details

Journal
BMC Public Health
Published
2026-11-13
DOI
https://doi.org/10.1186/s12889-026-30227-w
Primary Topic
Colorectal Cancer Screening and Detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The role of sigmoidoscopy in colorectal cancer screening – public preferences and predicted uptake

Christian Krauth, Melanie Brinkmann, Bernt‐Peter Robra, Kathrin Krüger et al.
2 links
BMC Public Health
Colorectal Cancer Screening and Detection
article

The role of sigmoidoscopy in colorectal cancer screening – public preferences and predicted uptake

Christian Krauth, Melanie Brinkmann, Bernt‐Peter Robra, Kathrin Krüger, Melissa Hemmerling, Maren Dreier, Jona Theodor Stahmeyer
article en

Abstract

BACKGROUND: Participation in cancer screening is crucial to maximise its benefit. In colorectal cancer (CRC) screening, stool tests or colonoscopies are commonly offered worldwide screening tests. In the German CRC screening programme, the insured can primarily choose between stool test and colonoscopy. However, sigmoidoscopy is also an evidence-based procedure to reduce CRC mortality and even prevent CRC. Based on individual preferences, we aim to estimate the uptake for either colonoscopy, sigmoidoscopy, or stool test in CRC screening. METHODS: In 2020, statutory insured individuals aged 50, 55, and 60 in Germany, Lower Saxony, were invited to participate in a discrete choice experiment (DCE). Each participant received 8 choice tasks, each of which presented two unlabelled (procedure A and B) screening alternatives defined by 6 attributes (CRC incidence and mortality, complications, preprocedural bowel preparation, need for transportation home, colonoscopy following a positive test result). Each attribute had 3 levels. To calculate the indirect utility and probability of uptake of stool testing, sigmoidoscopy, colonoscopy, and 'no screening', the preference weights of the attribute levels used to define the 4 alternatives were summed. Estimates were compared between standard screening (stool test or colonoscopy) and extended screening (+ sigmoidoscopy). External validity of the DCE was checked by comparing predicted and intended (2 items in the questionnaire) participation. RESULTS: From n = 666 valid respondents, a greater proportion of women (22.5%; 95%CI 16.2-28.9%) than men (13.4%; 95%CI 9.6-17.2%) preferred sigmoidoscopy in an extended screening scenario. Compared with standard screening, the predicted uptake for colonoscopy and the stool test as well as for 'no screening' was slightly lower when sigmoidoscopy was offered as an additional option. The extended screening could yield a slightly higher non-significant total participation in CRC screening in both women (+ 5.8%; 95%CI -0.4-12.0%) and men (+ 3.1; 95%CI -3.4-9.6%) than standard screening. Intended and preferred uptake did not differ substantially. CONCLUSIONS: A relevant proportion of the eligible population, more women than men, appears to prefer sigmoidoscopy for CRC screening when given the option. This additional option tends to increase overall predicted participation in CRC screening. Future studies are needed to evaluate the acceptance and feasibility of the additionally offered sigmoidoscopy in today's CRC screening. TRIAL REGISTRATION: DRKS00019010, 2019-11-18.

BMC Public HealthVol. 26(1)
Medizinische Hochschule Hannover (DE), Research Institute for Philosophy Hannover (DE), Hannover Re (Germany) (DE), Otto-von-Guericke-Universität Magdeburg (DE)
Good health and well-being
Colorectal Cancer Screening and Detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon